Equities

UPTD

US89268A1079

Delayed Nasdaq Other stock markets 09:30:37 2024-05-13 am EDT			5-day change	1st Jan Change
1.06 ^USD	-1.82%		+8.00%	-88.65%

2023	TradeUP Acquisition Corp.(NasdaqCM:UPTD) dropped from NASDAQ Composite Index	CI
2023	Estrella Immunopharma, Inc. announced that it has received $10 million in funding	CI

TradeUP Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

November 14, 2022 at 04:04 pm EST

TradeUP Acquisition Corp. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 0.344863 million compared to USD 0.107547 million a year ago.
For the nine months, net loss was USD 0.845701 million compared to USD 0.111921 million a year ago.

Latest news about TRAP ACQU

TradeUP Acquisition Corp.(NasdaqCM:UPTD) dropped from NASDAQ Composite Index	23-09-29	CI
Estrella Immunopharma, Inc. announced that it has received $10 million in funding	23-09-28	CI
Estrella Biopharma, Inc. completed the acquisition of TradeUP Acquisition Corp. from TradeUP Acquisition Sponsor LLC and others in a reverse merger transaction.	23-09-28	CI
Top Premarket Gainers	23-09-21	MT
TradeUP Acquisition Extends Deadline for Merger With Estrella Biopharma	23-09-19	MT
Top Premarket Gainers	23-09-18	MT
Top Premarket Decliners	23-09-05	MT
TradeUP Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-01	CI
TradeUP Acquisition Corp. announced that it has received $0.05 million in funding	23-07-19	CI
TradeUp Acquisition Extends Period for Completing Initial Business Combination to Aug. 19	23-07-19	MT
TradeUP Acquisition Extends Merger Deadline	23-06-21	MT
TradeUP Acquisition Corp. announced that it has received $0.06 million in funding	23-06-08	CI
TradeUP Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-18	CI
TradeUP Acquisition Left With Two More Deadline Extensions Under Current Charter for Initial Business Combination	23-04-14	MT
TradeUP Acquisition Extends Deadline for Initial Business Combination by One Month to May 19	23-04-14	MT
TradeUP Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
TradeUP Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
TradeUP Acquisition Corp. Auditor Raises 'Going Concern' Doubt	23-03-13	CI
TradeUP Acquisition Extends Deadline for Initial Business Combination	23-01-20	MT
TradeUP Acquisition Corp. announced that it has received $0.05 million in funding from TradeUP Acquisition Sponsor LLC	23-01-18	CI
TradeUP Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Estrella Biopharma to Go Public via SPAC Merger Deal	22-10-03	MT
Estrella Biopharma, Inc. entered into a definitive business combination agreement to acquire TradeUP Acquisition Corp. from TradeUP Acquisition Sponsor LLC and others for approximately $330 million in a reverse merger transaction.	22-10-02	CI
TradeUP Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-08	CI
TradeUP Acquisition Corp. announced that it has received $0.4986 million in funding from Running Lion Holdings Limited, TradeUp, Inc.	22-07-24	CI

Chart TRAP ACQU

Duration

Period

More charts

Company Profile

TradeUP Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search for a target business in automation, digitalization, energy efficiency and artificial intelligence within the technology sector. It has no operations and generates no revenues.

Sector

More about the company

Income Statement Evolution

More financial data